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Abstract
In the nervous system, Notch pathway has a prominent role in the control of neuronal morphology and in the
determination of the astrocyte fate. However, the role of Notch in morphological astrocyte plasticity is unknown. Here,
we have explored the role of Notch activity on the morphological reactivity of primary astrocytes in response to LPS,
an inﬂammatory stimulus. We found that LPS induces reactive astrocyte morphology by the inhibition of Notch
signaling via NFκB activation and Jagged upregulation. In contrast, IGF-1, an anti-inﬂammatory molecule, inhibits LPS-
induced reactive astrocyte morphological phenotype by enhancing Notch signaling through the inhibition of NFκB
and the activation of MAPK. Therefore, Notch signaling pathway emerges as a mediator of the regulation of astrocyte
morphology by inﬂammatory and anti-inﬂammatory stimuli.
Introduction
Reactive astrogliosis involves several processes that
astrocytes undergo under pathological conditions1–4. The
alterations suffered by reactive astrocytes vary with the
nature and severity of the insult. Modest metabolic sti-
mulus, infections, inﬂammatory processes or mild trauma
induce moderate reactive astrogliosis characterized by
changes in the molecular expression of pro-inﬂammatory
cytokines together with cellular hypertrophy. However, in
severe central nervous system (CNS) injury models,
astrogliosis also involves cell proliferation and scar
formation3.
Astrocytic hypertrophy of reactive astrocytes is char-
acterized by an increase in the number, thickness, and
length of the main cellular processes, which also present a
greater content in GFAP bundles than in nonreactive
astrocytes5. Although hypertrophy of astrocytes has been
profusely studied, the signaling mechanisms that regulate
morphological aspects of reactive astrogliosis remain
unclear.
Notch1 receptor and ligands, Delta-like-1 (Dll-1) and
Jaggeg-1 (Jag-1), have been extensively studied in relation
with cell fate speciﬁcation of neurons6–8, vascular smooth
muscle cells9, pancreatic endocrine cells10, and astro-
cytes11,12. In addition, Notch signaling regulates the
expression of molecules involved in the regulation of cell
morphology in developing neurons13,14. The canonical
trans-activation of the Notch pathway starts with the
binding of the extracellular domain of the ligand to the
extracellular domain of the receptor expressed in an
adjacent cell. This allows a conformational change in the
receptor that favors its cleavage by metalloproteases and
by the enzymatic complex γ-secretase, resulting in the
release of the intracellular domain of Notch (NICD), the
active fragment of the receptor. NICD is then translocated
into the cell nucleus, where it initiates the transcription of
Notch target genes, mainly hairy and enhancer of
split (HES)-1 and 56,15, the main effectors of the pathway
in the CNS16. Hes-1 and Hes-5 play a crucial role in
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neurogenesis, gliogenesis, neuritogenesis as well as
in the development of sensory organs17–19. In the
adult brain, Notch is involved in long-term memory20,
dendritic plasticity8, synaptic plasticity21, and postnatal
neurogenesis22.
Even if Notch functions in differentiated glial cells have
not been deeply investigated, it is clear that it plays a role
in neuroinﬂammation. For instance, Notch regulates
microglia activation and pro-inﬂammatory cytokine
release by its interaction with NFκB23,24. It has also been
shown that hypertrophic astrocytes express Jag-1 in vivo25
and that the intermediate ﬁlaments GFAP and vimentin
control Notch pathway activity in astrocytes5. Further-
more, Notch pathway regulates proliferation in reactive
astrocytes surrounding an ischemic lesion26,27. However,
the implication of Notch signaling in the morphological
changes experimented by reactive astrocytes has not been
explored previously.
In the present study, we have assessed whether Notch
signaling is involved in the activation of astrocytes by an
inﬂammatory challenge: the treatment with the bacterial
endotoxin lipopolysaccharide (LPS). We have also
explored whether Notch signaling in astrocytes is regu-
lated by insulin-like growth factor 1 (IGF-1), since this
factor reduces the astrocytic response to inﬂammatory
stimuli and their expression of inﬂammatory mediators
such as interleukin 6 (IL-6), tumor necrosis factor-α
(TNF-α), interleukin-1β (IL-1β), toll-like receptor 4, and
iNOS28,29.
Results
LPS induces a reactive inﬂammatory phenotype in primary
astrocytes
Reactive astrogliosis is a set of changes that occur in
astrocytes in response to CNS injury or disease. We
evaluated the use of mouse primary astrocyte cultures
exposed to LPS during 24 h, as a model of in vitro
astrogliosis29. The addition of LPS in concentrations
ranging from 50 to 5000 ng/mL did not decrease cell
viability, as assessed by a FDA test (Fig. 1a). In addition,
immunocytochemistry of astrocytes treated with BrdU
showed that LPS treatment did not change cell pro-
liferation (Fig. 1b). However, 100 and 500 ng/mL LPS
induced a signiﬁcant increase in the optical density in the
MTS test, while the dose of 5000 ng/mL LPS decreased
the optical density compared to the control group
(Fig. 1c). Based on the results of FDA test and of BrdU
quantiﬁcation, the changes observed in MTS test may
represent differences in cell metabolic activity induced by
LPS treatment.
Stimulation of astrocytes with 500 ng/ml LPS also
enhanced the expression of two of the main pro-
inﬂammatory factors released by reactive astrocytes: the
cytokine IL-6 and the chemokine IP-10 (Fig. 1d).
Moreover, this LPS dose induced changes in astrocyte
morphology that are compatible with an increased reac-
tivity. Thus, as shown in Fig. 1e, the percentage of cells
with bipolar and stellate shapes was higher in the cultures
treated with LPS than in the control conditions. There-
fore, we established a model that at least mimics some of
the main components of reactive astrogliosis by exposing
primary cultures of cortical astrocytes to 500 ng/mL LPS
for 24 h.
Notch signaling is regulated by LPS in astrocytes
To determine the possible implication of the Notch
signaling pathway in the changes induced by LPS in
astrocytes, we evaluated the mRNA expression of differ-
ent genes related with Notch signaling. LPS positively
regulated the transcription of the ligand Jagged-1 (Jag-1)
while signiﬁcantly reduced the expression of the Notch-1
receptor and the Notch-1 effector Hes-5 (Fig. 2a). In
contrast, LPS did not signiﬁcantly affect the expression of
Dll and Hes-1 (Fig. 2a).
NFκB activation is involved in the transcriptional
regulation of Jag-1 and Hes-5 by LPS
We had already demonstrated that the increase in the
expression of pro-inﬂammatory cytokines by astrocytes in
response to LPS is mediated by NFκB activation30.
Accordingly, in our model, the NFκB inhibitor BAY-11,
signiﬁcantly reduced the effect of LPS on the transcription
of IL-6 and IP-10 (Fig. 2b, c). In addition, the upregulation
of Jag-1 and the downregulation of Hes-5 induced by LPS
were abrogated by this drug (Fig. 2d, e), indicating that the
transcriptional effect of LPS on Jag-1 and Hes-5 depends
on activation of NFκB. In contrast, the effect of LPS on
Notch-1 transcription was not modiﬁed by BAY-11
(Fig. 2f).
Hes-5 downregulation by LPS in astrocytes is mediated by
a decrease in NICD
We also evaluated the levels of the Notch intracellular
domain (NICD), which is released when Notch is acti-
vated. We observed that the astrocytes stimulated with
LPS had lower amounts of NICD than control ones
(Fig. 3a). Furthermore, we transfected a NICD-expressing
myc-tagged plasmid into primary astrocytes. Constitutive
expression of NICD generated an activated Notch phe-
notype that was conﬁrmed by a signiﬁcant increase in
Hes-5 mRNA expression (Fig. 3b). Interestingly, NICD
overexpression prevented the LPS-induced Hes-5 tran-
scriptional downregulation observed in control astrocytes,
clearly indicating that Hes-5 downregulation provoked by
LPS in astrocytes relies upon Notch-1 processing and
NICD release (Fig. 3b).
NICD overexpression in astrocytes did not modify Jag-1
mRNA expression under control conditions, nor
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prevented its induction by LPS (Fig. 3c). Besides, the
addition of DAPT (the γ-secretase inhibitor) to the
astrocytic cultures did not alter Jag-1 mRNA expression
(Fig. 3d), indicating that Jag-1 transcription is not under
the control of Notch-1 receptor activation.
Notch signaling is involved in the effect of LPS on
astrocyte morphology
Astrocytes were also transfected with NICD-expressing
plasmid to determine whether Notch signaling is involved
in the morphological effects of LPS on these cells. Over-
expression of NICD in astrocytes resulted in a signiﬁcant
increase in the proportion of cells with a polygonal
morphology and in a signiﬁcant decrease in the propor-
tion of bipolar cells compared to control astrocytes
transfected with the empty vector (Fig. 4a). This suggests
that Notch signaling regulates astrocyte morphology
under basal conditions. In addition, the treatment with
LPS of astrocytes transfected with the empty vector
resulted in a signiﬁcant decrease in the proportion of cells
with polygonal morphology and a signiﬁcant increase in
the proportion of cells with stellate morphology compared
to control astrocytes (Fig. 4a). The morphological effect of
LPS was blocked in the NICD overexpressing astrocytes
(Fig. 4a), suggesting that Notch signaling mediates the
effect of LPS on astrocyte morphology.
In contrast to astrocyte morphology, the expression of
IL-6 and IP-10 under basal conditions and after LPS sti-
mulation was not affected by overexpression of NICD in
astrocytes (Fig. 4b, c). This suggests that canonical Notch-
1 signaling does not mediate the expression of IL-6 and
IP-10 under basal conditions and does not mediate their
upregulation by LPS.
IGF-1 regulates Notch signaling and morphology in
astrocytes
IGF-1 is a neuroprotective factor that is known to
reduce reactive astrogliosis by the inhibition of NFκB in
astrocytes29,31,32. Since our previous results indicate that
NFκB is involved in the regulation of Notch signaling, we
Fig. 1 LPS stimulation of primary astrocytes. a LPS stimulation (500 ng/mL) during 24 h preserves cell viability as it was evaluated by FDA
ﬂuorescence emission and b it does not modify cell proliferation analyzed by immunocytochemistry against BrdU. c MTS oxidation rate
(mitochondrial respiration) is modiﬁed by LPS. * Signiﬁcant differences (p < 0.05) versus control (Student’s t-test, n= 4). d LPS treatment induces the
transcription of pro-inﬂammatory cytokines; ** signiﬁcant differences (p < 0.01) versus control (Student’s t-test, n= 4). e Astrocytes exposed to LPS
display a signiﬁcant change in their morphology, transitioning from a polygonal shape towards more elongated (bipolar and stellate) shapes.
Immunoﬂuorescence images show an example of the three types of astrocytes morphology in cultures, after immunostaining with an antibody
against GFAP. Graphs represent the percentage of each cell type in the culture. *signiﬁcant differences (p < 0.05) versus control polygonal cells.
$signiﬁcant differences (p < 0.05) versus control bipolar cells. #signiﬁcant differences (p < 0.05) versus control stellate cells (Student’s t-test, n= 4)
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hypothesized that IGF-1 could regulate Notch signaling in
astrocytes.
To explore this possibility, astrocyte cultures were
treated with the growth factor for 24 h. In addition, some
cultures were pre-treated for 4 h with NVP, a speciﬁc
inhibitor of IGF-1R, and then stimulated with IGF-1 for
24 h. The expression levels of Hes-5 mRNA were mea-
sured by real-time PCR. IGF-1 increased the expression of
Hes-5 (Fig. 5a) and NVP signiﬁcantly reduced this effect,
indicating that the effect of IGF-1 on the regulation of
Notch pathway is mediated, at least in part, by its binding
to IGF-1R.
To test whether the PI3K or the MAPK pathways, which
are activated by IGF-1R, mediate the effect of IGF-1 on
Notch signaling, we stimulated astrocytes in the presence
of selective inhibitors of these two signaling pathways.
Astrocytes were pre-treated for 4 h with each inhibitor
and then stimulated with IGF-1 for 24 h. Levels of Hes-5
mRNA transcription were measured by real-time PCR
(Fig. 5b) and the levels of NICD were measured by wes-
tern Blot (Fig. 5c). IGF-1 signiﬁcantly increased the levels
of Hes-5 mRNA (Fig. 5b) and the levels of NICD (Fig. 5c).
Inhibition of the PI3K pathway with wortmannin did not
signiﬁcantly affect the action of IGF-1. However, the
blockade of the MAPK pathway with U0126 resulted in a
total inhibition of Hes5 expression (Fig. 5b) and NICD
production (Fig. 5c).
Since our results indicate that Notch signaling mediates
the morphological changes induced by LPS on astrocytes
and that IGF-1 regulates Notch signaling, we decided to
assess whether IGF-1 regulates astrocyte morphology.
Fig. 5d shows that IGF-1 increased the proportion of
astrocytes with a polygonal morphology and decreased
the proportion of bipolar astrocytes. This effect is oppo-
site to the effect of LPS and seems to depend on Notch
signaling since it was blocked by DAPT, indicating that it
depends on the γ-secretase activity.
IGF-1 blocks the effect of LPS on Notch signaling and
morphology in astrocytes
Since IGF-1 exerted opposite effects to LPS on Notch
signaling, we tested whether IGF-1 could counteract the
effect of LPS on Notch signaling in astrocytes. Fig. 6a
shows that, in agreement with our previous experiments,
Fig. 2 LPS regulates Notch signaling in primary astrocytes. a LPS treatment induces the transcription of the ligand Jagged-1, while reduces the
expression of the receptor Notch-1 and the effector Hes-5. *, **, *** signiﬁcant differences (p < 0.05, p < 0.01, and p < 0.001) versus control (Student’s t-
test, n= 4). b–e The NFκB inhibitor BAY-1 is able to signiﬁcantly reduce the LPS-induced increase in the transcription of IL-6, IP-10, and Jag-1 (b–d)
and decrease of Hes-5 (e). f LPS downregulation on Notch-1 transcription is not modiﬁed by BAY-11. Statistical signiﬁcance was determined using
one-way ANOVA and Bonferroni post hoc test; *, **, ***signiﬁcant differences (p < 0.05, p < 0.01, and p < 0.001) versus control. $signiﬁcant differences
(p < 0.05) versus LPS
Acaz-Fonseca et al. Cell Death Discovery            (2019) 5:85 Page 4 of 14
Ofﬁcial journal of the Cell Death Differentiation Association
the addition of IGF-1 to the astrocyte cultures increased
Hes-5 mRNA levels and abrogated the reduced expression
of Hes-5 induced by LPS. In addition, IGF-1 signiﬁcantly
decreased the expression of Jag-1 and counteracted the
upregulation of Jag-1 by LPS (Fig. 6b).
Astrocytes treated with IGF-1 showed a striking
increase in NICD levels (Fig. 6c), indicating a strong
Notch activation. LPS was able to signiﬁcantly reduce
NICD levels in the astrocytes treated with IGF-1. How-
ever, NICD levels in astrocytes treated with LPS and IGF-
1 were much higher than the levels in astrocytes treated
with LPS alone. This indicates that Notch maintains a
high degree of activation in IGF-1 treated astrocytes even
in the presence of LPS. Treatment of astrocytes with
DAPT blocked the effect of IGF-1 on NICD levels
(Fig. 6c), on Hes-5 expression (Fig. 6d) and on Jag-1
expression (Fig. 6e) suggesting that the effect of IGF-1 on
Notch signaling depends on the γ-secretase activity.
As our results indicated that IGF-1 neutralizes the effect
of LPS on Notch signaling in astrocytes, we decided to
assess whether IGF-1 was also able to block the changes
induced by LPS on astrocyte morphology. Fig. 6f shows
that IGF-1 counteracted the effect of LPS on the pro-
portion of astrocytes with polygonal and bipolar
morphology.
Jag-1 depletion impairs the effect of LPS on the astrocyte
morphology
The above experiments show that astrocytes treated
with LPS have higher levels of Jag-1 expression and more
reactive morphology. On the contrary, cultures treated
with IGF-1 present Jag-1 downregulation and more
Fig. 3 Hes-5 downregulation by LPS in astrocytes is mediated by a decrease in NICD. a Representative immunoblot shows NICD expression
levels in astrocytes cultures treated with LPS. Actin was used as a loading control. Statistical signiﬁcance (p < 0.01) was determined using Student’s t-
test, n= 7. b, c The inﬂuence of LPS on the expression of Hes-5 and Jag-1 determined by qPCR in astrocytes cultures overexpressing NICD. **,
***Signiﬁcant differences (p < 0.01 and p < 0.001) versus control cultures that express myc-tag and $signiﬁcant difference (p < 0.05) versus control that
express myc-NICD (Student’s t-test, n= 4). d Expression of Jag-1 determined by qPCR in cultures treated with DAPT
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resting morphology. To directly assess the role of Jag-1 on
astrocyte morphology, we transfected astrocyte cultures
with a speciﬁc Jag-1-siRNA. The silencing efﬁcacy was
conﬁrmed measuring Jag-1 expression by real-time PCR
(Fig. 7a) and by western blotting (Fig. 7b). We found that
silencing of Jag-1 expression had no effect on IL-6
(Fig. 7c) and IP-10 (Fig. 7d) mRNA levels, under basal
conditions and after LPS stimulation. In contrast, Jag-1
silencing impaired the effect of LPS on astrocyte mor-
phology (Fig. 7e).
Discussion
Our ﬁndings indicate that Notch signaling is involved in
the reactive morphological changes of astrocytes in
response to a pro-inﬂammatory stimulus, such as LPS.
Indeed, our data suggest that the effects of LPS on
astrocyte morphology depend on the upregulation of Jag-
1 by NFκB. In turn, Jag-1 upregulation causes the
downregulation of NICD, which mediates the change in
astrocyte morphology. In contrast, Notch signaling is not
involved in the upregulation of the pro-inﬂammatory
molecules IL-6 and IP-10 in response to LPS.
Our results show that LPS decreases the expression of
Hes-5 and Notch-1 and increases the expression of Jag-1,
but does not affect the expression of Dll. The increased
expression of Jag-1 by LPS is in concordance with pre-
vious results that shown that Jag-1 is under the control of
the NFκB signaling pathway33,34 and that LPS activates
NFκB in astrocytes by promoting the translocation of
p65/NFκB subunit to the cell nucleus30.
Canonical Notch signaling is initiated by ligand binding
to the Notch receptor on neighboring cells, which leads to
the proteolytic processing of the receptor and the release
of NICD. Nevertheless, our experiments demonstrate that
LPS induces changes in astrocyte morphology by blocking
Notch signaling, while enhancing the mRNA expression
of Jag-1. Jagged ligands have been described as inhibitory
or antagonistic for the activation of Notch signaling by
Dll35. Several studies demonstrated that Dll and Jagged
may have opposite functions. In angiogenesis, activation
of Notch by Dll4 inhibits tip cell selection36. In contrast,
Jagged-Notch signaling promotes tip cell selection and
sprouting by antagonizing Dll4-Notch signaling35,37,38.
These ﬁndings clearly show that the balance between the
Fig. 4 Notch activation counteracts the effect of LPS on astrocytes morphology but not on the transcription of pro-inﬂammatory
cytokines. a Notch activation by overexpressing NICD in the culture, changes astrocyte morphology in the opposite way that LPS: increases the
proportion of polygonal cells, decreases the proportion of bipolar cells and does not change the stellates. Overexpression of NICD rescues the
phenotype to control values in LPS treated astrocytes. Statistical signiﬁcance was determined using one-way ANOVA and Bonferroni post hoc test for
each phenotype separately, *signiﬁcant differences (p < 0.05) versus their respective control, n= 4. b, c Notch activity does not modulate pro-
inﬂammatory cytokines expression and does not interact with the effect of LPS on their expression. ***signiﬁcant differences (p < 0.001) versus
control cultures that express myc-tag and $$$signiﬁcant differences (p < 0.001) versus control that express myc-NICD
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two Notch ligands is a key factor in cell fate deﬁnition and
in cell morphology acquisition. Inhibition of Notch sig-
naling by γ-secretase inhibitors or Dll blockade produces
hyperbranching in endothelial cells; however, Jagged
inhibition decreases branching and reduces angiogen-
esis37,39. The attenuation of Notch signaling induced by
Jag-1 can be attributed to cis-inhibition by Jag-1 binding
to the Notch receptor and inhibition of the signal medi-
ated Dll in receiver cell40–43.
Considering the different function of the two Notch
ligands, the LPS-induced altered balance in the expression
of Jag-1 and Dll in astrocytes may explain that the
increase in Jag-1 expression after LPS is associated with
lower levels of NICD and Hes-5, indicating an inhibition
of Notch signaling. When NICD was overexpressed in
astrocytes, LPS was unable to modify the expression of
Hes-5, indicating that the effect of LPS on Notch activity
is produced by the canonical signaling pathway15. Fur-
thermore, Jag-1 silencing or NICD overexpression in
astrocytes resulted in a resting cellular phenotype after
LPS stimulation, suggesting that increased Jag-1 expres-
sion and the consequent reduction in Notch activity
mediates the effect of LPS in the induction of reactive
morphology.
The involvement of Notch signaling in the morphology
of astrocytes after LPS stimulation may be relevant for the
mechanisms of reactive gliosis. Thus, reactive astrocytes
present hypertrophy of cell body and increase the thick-
ness of their main cellular processes5,44. Further studies
should determine whether Notch signaling is also
Fig. 5 IGF-1 regulates Notch signaling and morphology in astrocytes. a IGF-1-induced Hes-5 overexpression involves IGF-1R. b. c IGF-1 increases
Hes-5 transcription (b) and NICD production (c) through MAPK pathway. **, ***signiﬁcant differences (p < 0.01 and p < 0.001) versus control cells. &&,
&&&signiﬁcant differences (p < 0.01 and p < 0.001) versus IGF-1-treated cells. d To determine whether exogenous addition of IGF-1 is able to modify
astrocyte morphology, primary cultures were treated with 100 nM IGF-1 alone or in the presence of DAPT. Graph represents the percentage of cell
type in each condition. Statistical signiﬁcance was determined using one-way ANOVA and Bonferroni post hoc test for each phenotype separately, **,
***(p < 0.01 and p < 0.001) versus their respective control; &&&(p < 0.001) versus IGF-1-treated astrocytes, n= 4. Note that the effect of IGF-1 on
astrocyte morphology is similar to NICD expression and opposite to LPS treatment
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involved in the changes in morphology of microglia,
which upon stimulation changes from a ramiﬁed, quies-
cent morphology to an amoeboid, activated
morphology45.
In microglia cells, Notch signaling ampliﬁes the pro-
inﬂammatory response by enhancing NFκB/
p65 signaling23,24, suggesting that both pathways syner-
gistically regulate the inﬂammatory function in activated
microglia. In contrast, in astrocytes our ﬁndings indicate
that this signaling pathway is not involved in the effect of
LPS on the expression of pro-inﬂammatory molecules.
This further suggests that the regulation of Notch sig-
naling in astrocytes by LPS is downstream of NFκB acti-
vation since the inhibition of NFκB with BAY-11 blocked
the upregulation of Jag-1 and the downregulation of Hes-
5 by LPS. Previous studies have shown that LPS-mediated
production of cytokines by astrocytes involves the acti-
vation of the NFκB pathway30,46,47. Thus, we may hypo-
thesize that NFκB stimulates neuroinﬂammation in
reactive astrocytes by the upregulation of pro-
inﬂammatory molecules and, in parallel, by the upregu-
lation of Jag-1, which induces reactive morphological
changes in astrocytes (Fig. 8a).
IGF-1 regulates inﬂammation in a context-dependent
manner. In the brain, several studies showed anti-
inﬂammatory effects of IGF-1 acting on astrocytes and
microglia and revealed that IGF-1 levels may be critical
for regulating the neuroinﬂammatory response48.
Experiments in vivo show that the level of IGF-1 increases
at the injury site, but at least part of it comes from the
periphery in response to brain damage49. Following this
paradigm, we analyzed the effect of exogenous IGF-1 in
Fig. 6 IGF-1 counteracts the effect of LPS on Notch signaling and astrocyte morphology. a, b Expression levels of Hes-5 and Jag-1 in cortical
astrocytes treated with IGF-1 alone or in the presence of LPS. c–e LPS and gamma-secretase activity mediate IGF-1-induced Noth-1 cleavage (c) and
Hes-5 (d) and Jag-1 (e) transcription in cortical astrocytes in vitro. *, **, ***signiﬁcant differences (p < 0.05, p < 0.01 and p < 0.001) versus control cells; &,
&&&signiﬁcant differences (p < 0.05 and p < 0.001) versus IGF-1-treated cells; $$$signiﬁcant difference (p < 0.001) versus LPS treated cells and % (p <
0.05) signiﬁcant difference versus DAPT-treated cells (one-way ANOVA and Bonferroni post hoc test, n= 4). f IGF-1 is able to counteract the effect of
LPS on astrocytes morphology. Graph represents the percentage of cell type in each condition. Statistical signiﬁcance was determined using one-way
ANOVA and Bonferroni post hoc test for each phenotype separately, ***(p < 0.001) versus their respective control; $$(p < 0.01) versus LPS-treated
astrocytes, n= 4
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Fig. 7 Jag-1 downregulation rescues the effect of LPS on astrocyte morphology but not on the transcription of pro-inﬂammatory
cytokines. Astrocytes were transfected with a speciﬁc Jag-1 and a non-target siRNA, and then exposed to LPS. a, b Jag-1-siRNA signiﬁcantly
decreased both Jag-1 mRNA (a) and protein expression (b). c, d Jag-1 downregulation do not alter the expression of pro-inﬂammatory cytokines
under either control or inﬂammatory conditions. *, ***signiﬁcant differences (p < 0.05 and p < 0.001) versus control non-target siRNA; ^, ^^,
^^^^signiﬁcant difference (p < 0.05, p < 0.01 and p < 0.001) versus control Jag-siRNA and ###(p < 0.001) signiﬁcant difference versus non-target siRNA
transfected cells (one-way ANOVA and Bonferroni post hoc test, n= 4). E. Jag-1 downregulation abolishes the effects of LPS on astrocyte
morphology. Statistical signiﬁcance was determined using one-way ANOVA and Bonferroni post hoc test for each phenotype separately, *, ***(p <
0.05 and p < 0.001) versus their respective control
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astrocytes. Our ﬁndings indicate that Notch signaling in
astrocytes also mediates their morphological transforma-
tion induced by IGF-1. In contrast to LPS, IGF-1 induced
a signiﬁcant decrease in the expression of Jag-1 and a
signiﬁcant increase in the levels of NICD and the
expression of Hes-5. Thus, IGF-1 and LPS had opposite
effects on Notch signaling in astrocytes (activation and
inhibition, respectively). In agreement with this, IGF-1
and LPS exerted also opposite effects on astrocyte mor-
phology. Thus, IGF-1 decreased, while LPS increased, the
proportion of astrocytes with reactive morphology, an
effect that was mediated by γ-secretase. In addition, IGF-1
was able to counteract the effect of LPS on Notch sig-
naling and on astrocyte morphology. Since Jag-1 expres-
sion is regulated by NFκB signaling (our present ﬁndings)
and NFκB pathway is blocked by IGF-131, we may hypo-
thesize that the action of IGF-1 on Notch signaling is
upstream of NFκB. Nevertheless, the IGF-1 induced
decrease in Jag-1 expression is not enough to explain the
huge accumulation of NICD generation and the change in
astrocyte morphology. Jag-1 mRNA downregulation in
astrocytes was achieved by siRNA and by IGF-1 treat-
ment, however, only the later was able to increase the
percentage of cells displaying less reactive shapes. Block-
ade of MAPK pathway completely suppress IGF-1 pro-
duction of NICD as well as increased expression of Hes-5.
So our results suggest that actions of IGF-1 on astrocytes
involve both, blockade of NFκB pathway and activation of
MAPK signaling (Fig. 8b).
In summary, our ﬁndings demonstrate for the ﬁrst time,
that Notch signaling is involved in the morphological
changes induced in astrocytes by inﬂammatory and anti-
inﬂammatory factors, expanding the known roles of
Notch to the regulation of astrocyte morphology.
Materials and methods
Animals
Postnatal day 0 (PND0)–PND2 male and female CD1
mouse pups were raised in our in-house colony at the
Cajal Institute. Male pups were distinguished from female
pups by a larger genital papilla and longer anogenital
distance. All the procedures applied to the animals used in
this study were in accordance with the European Com-
mission guidelines (2010/63/UE) and the Spanish reg-
ulation (R. D. 53/2013) on the protection of animals for
experimental use. These procedures were approved by our
institutional animal care and use committee (Comité de
Ética de Experimentación Animal del Instituto Cajal) and
the Consejería del Medio Ambiente y Territorio (Comu-
nidad de Madrid, PROEX 200/14).
Cortical astrocyte cultures
Astrocytes were cultured from male and female
PND0–PND2 pups (50% each). The brain was extracted,
meninges were removed, and the cerebral cortex was
isolated under a dissecting microscope and then
mechanically dissociated and washed twice in Hank’s
balanced salt solution (Sigma-Aldrich, Tres Cantos,
Madrid). After complete dissociation in Dulbecco’s
modiﬁed Eagle’s medium/Nutrient mixture F-12
(DMEM/F-12) culture medium with phenol red (Sigma-
Aldrich) containing 10% fetal bovine serum (FBS, Invi-
trogen, Carlsbad, CA) and 1% antibiotic–antimycotic
(Invitrogen), the cells were ﬁltered through a 40 μm nylon
cell strainer (Corning Inc., Corning, NY). The cells were
centrifuged, resuspended in the same medium, and plated
onto poly-L-lysine-coated 75-cm2 ﬂasks at 37 °C and 5%
CO2. The medium was replaced after the ﬁrst day in vitro
and twice per week until the cells reached conﬂuence
(~7 days). Then, the cell cultures were shaken overnight at
37 °C and 280 rpm on a tabletop shaker (Infors HT,
Bottmingen, Switzerland) in order to minimize oligo-
dendrocyte and microglia contamination. The astrocytes
were incubated with 0.5% trypsin (Sigma-Aldrich), cen-
trifuged, resuspended in DMEM/F-12 with 10% FBS and
1% antibiotic–antimycotic, and seeded in poly-L-lysine-
coated 75-cm2 ﬂasks at 37 °C and 5% CO2. When the
cells reached conﬂuence for the second time (~ after
5 days), the subculture process was repeated but the
astrocytes were plated onto poly-L-lysine-coated plates (6,
Fig. 8 Summary of the effects of LPS and IGF-1 on Notch
signaling in astrocytes. a Inﬂammatory conditions in primary
astrocytes: LPS activates NFκB that promotes the expression of (1)
molecules that generate inﬂammation and (2) the Notch ligand Jag-1
that reduces Notch activity and consequently induce a reactive
morphology in astrocytes. b Anti-inﬂammatory conditions in primary
astrocytes: IGF-1 produces an increase of Notch activity by: (1)
activating MAPK signaling pathway and (2) reducing Jag-1 NFκB-
dependent expression. Both IGF-1 effects drive to enhance Hes-5
expression and result in a resting morphology in astrocytes
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24, or 48 wells) or glass coverslips using DMEM/F-12 with
10% FBS and 1% antibiotic–antimycotic. Using this pro-
tocol we obtained cultures with less than 4% of Iba-1
positive cells, checked by double immunocytochemistry
with anti-Iba I (microglial marker) and anti-GFAP anti-
bodies (astroglial marker). Fibroblast contamination was
also assessed by immunocytochemistry using an anti-Thy
1 antibody (against CD90, 1:500), but no staining was
detected.
Cell treatments
When cells were conﬂuent in the multiwell plates, they
were rinsed once with pre-warmed PBS and then the
treatments were applied in DMEM-F12 without additives.
Cells were pre-treated with the inhibitory drugs (Table 1)
for 4 h, and then IGF-1 (100 nM), and/or LPS (500 ng/mL)
were added to the culture medium for 24 h.
Cell viability assay
The non-cytotoxic dose of LPS used for all the experi-
ments was set after the analyses of a dose-viability curve
using LPS at ﬁnal concentrations from 50 to 5000 ng/mL
in the culture. To assess cell viability, we performed the
ﬂuorescein diacetate (FDA)/propidium iodide (PI) assay.
Cells were seeded in 24-well plates and treated for 24 h
with increasing concentrations of LPS (in phenol red-free
DMEM-F12 medium without additives). Just before the
end of the treatment, cells were incubated for 50 min at
37 °C with FDA (100 μM) and PI (15 μM). Fluorescence at
520 and 620 nm wavelength was measured in a plate
reader (FluoStar OPTIMA, BMG Labtech, Germany).
To evaluate the cells metabolic activity (mitochondrial
respiration), the 3-(4,5-dimethylthiazol-2-yl)-5-(3-car-
boxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium,
inner salt (MTS) assay was performed with the same LPS
concentrations (50–5000 ng/mL). Astrocytes were plated
in 48-well microplates and treated for 24 h with LPS at
concentrations of 50, 100, 500, 1000, or 5000 μg/mL. After
the addition of 20 μL of CellTiter 96 AQueous One
Solution (Promega, Madison, USA), the plates were
incubated for 4 h at 37 °C and 5 % CO2. Absorbance at
490 nm wavelength was measured in a plate reader.
Proliferation assay
Astrocytes were seeded in glass coverslips (pre-coated
with poly-l-lysine) at a density of 25,000 cells/cm2 and
exposed to a 30 min-pulse of BrdU (bromodeoxyuridine,
10 µM) in order to assess cell proliferation. BrdU
incorporation was detected by double immunocy-
tochemistry using antibodies against BrdU and GFAP.
Brieﬂy, paraformaldehyde-ﬁxed cells were incubated
with 2 N HCl/ 0.5% triton X-100 during 30 min at room
temperature. Then, pH was neutralized with sodium
tetraborate and primary and secondary antibodies were
added.
Transfections
Astrocytes were transfected at 60% of conﬂuence using
the Effectene Transfection Reagent (Qiagen GmbH, Hil-
den, Germany), following the manufacturer’s instructions.
Cells were transfected with a pcDNA1 vector encoding a
myc epitope and NICD50 using the empty vector as
control; other cultures were co-transfected with pmax-
GFP plus small interfering RNA (siRNA) oligonucleotide
targeted to Jag-1. After 20 h of expression time, cells were
treated with the indicated drugs for each assay during 24
h. Then the astrocytes were harvested and processed for
real-time polymerase chain reaction (PCR) and western
blot analysis or ﬁxed in 4% paraformaldehyde in 0.1M
phosphate buffer for immunostaining.
SiRNA oligonucleotides were purchased from Applied
Biosystems/Ambion and the concentration was 30 nM
during transfection. SiRNAs targeting Jag-1 was Silencer®
Select siRNA ID # s68530. A non-targeting siRNA was
used as negative control (Silencer® Select Negative Con-
trol #1 siRNA, catalog number 4390843).
Quantitative RT-PCR
Total RNA was extracted from cultures with Illustra
RNAspin Mini RNA isolation kit from GE Healthcare
(Buckinghamshire, UK). First strand cDNA was pre-
pared from RNA using the Moloney murine leukemia
virus reverse transcriptase (Promega Corp., Madison,
Wisconsin) following the manufacturer’s instructions.
Quantitative PCR reactions were carried out on an ABI
Prism 7500 Sequence Detector (Applied Biosystems,
Weiterstadt, Germany) using the TaqMan or Sybr
Green Universal PCR Master Mix. TaqMan probe and
primers for Hes-5 were Assay-on-Demand gene
expression products (Applied Biosystems). Primer
sequences for the rest of genes evaluated and control
housekeeping gene 18S rRNA, were designed using
Primer Express (Applied Biosystems) (Table 2). All
reactions were done in duplicates, from at least 4 dif-
ferent cultures. Gene expression was normalized for 18S
rRNA expression. The ΔΔCT method was used for
relative quantiﬁcation analysis.
Table 1 Inhibitory drugs
Target Inhibitor Concentration Supplier
IGF-1R NVP 400 nM Cayman Chemical
PI3K Wortmannin 100 nM Calbiochem
MEK 1/2 U1026 10 µM Cell Signaling
γ-secretase DAPT 2,5 µM Calbiochem
NFκB BAY-11 10 µM Calbiochem
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Western blot
Primary cultures were lysed in 150 µL of Laemmli buf-
fer, heated during 5min at 100 °C and sonicated for 5 min.
Solubilized proteins (30 µL) were resolved in 8–10% SDS-
PAGE bis-acrylamide gels and transferred to nitrocellu-
lose membranes (Trans-Blot turbo transfer pack, Biorad)
in a semi-dry system (Trans-Blot Turbo Transfer System,
Biorad). Membranes were blocked for 2 h in a 5% BSA-
TTBS (138mM NaCl, 25 mM Tris-HCl, pH 8.0 and 0.1%
Tween-20) solution, and incubated overnight with the
primary antibodies (Table 3) at 4 °C under moderate
shaking. Anti-β-actin, anti-Tubulin and anti-GAPDH
mouse monoclonal antibodies were used as loading con-
trols. All secondary antibodies were from Jackson
Immuno Research (West Grove, PA, USA). Proteins were
visualized with a chemiluminescence detection reagent
according to the manufacturer’s instructions (Amersham,
GE Healthcare Europe, Barcelona, Spain). The densito-
metric analysis of scanned ﬁlms was performed with
ImageJ software (Maryland, USA. http://imagej.nih.gov/).
Immunocytochemistry
Cells were seeded in glass coverslips (pre-coated with
poly-l-lysine) at a density of 25,000 cells/cm2. After the
appropriate treatments, astrocytes were ﬁxed for 20 min
with 4% paraformaldehyde at room temperature and
permeabilized for 4 min with 0.12% Triton-X plus 0.12%
gelatin in PBS. Cells were then washed with PBS/gelatin
and incubated for 1 h with primary antibodies (Table 3).
After washing in the same buffer, cells were incubated for
45 min at room temperature with the proper ﬂuorescent
secondary antibodies (Table 3). For morphology assess-
ment, GFAP-positive cells were classiﬁed into three dif-
ferent categories: Polygonal astrocytes were those
without any cytoplasmic protrusions, Bipolar astrocytes
presented an elongated cell body or one thin and long
protrusion, and Stellate astrocytes were those with a
reduced cell body and three or more long ramiﬁcations
(Fig. 1e).
Statistical analysis
Data shown in the ﬁgures are the result of 4–10 inde-
pendent experiments and are presented as the mean ±
standard error of the mean (SEM). Statistical analyses
were carried out using SPSS Statistics 23 software (IBM,
Armonk, NY). Gaussian distribution of data sets was
assessed by Kolmogorov–Smirnov test. Statistical sig-
niﬁcance was evaluated by the unpaired Student´s T-test
for one to one comparisons, and by two-way analysis of
variance (ANOVA) followed by Bonferroni or Games-
Howell post hoc tests (depending on whether variances
were homogeneous or not, respectively) for multiple
Table 2 Primer sequences for real-time polymerase chain reaction
Gene Symbol Forward 5´–3´ Reverse 5´–3´
18S-rRNA CGCCGCTAGAGGTGAAATTCT CATTCTTGGCAAATGCTTTCG
Hes-1 CCAGCCAGTGTCAACACGA AATGCCGGGAGCTATCTTTCT
Notch-1 CCCTTGCTCTGCCTAACGC GGAGTCCTGGCATCGTTGG
Dlk-1 AATGTCTGCAGGTGCCATGTT TGCACTGCCATGGTTCCTT
Jag-1 TCAGGACACACAACTCGGAAGT CTCCTCTCTGTCTACCAGCGTATACA
IGF-1 GTGATCTGAGGAGACTGGAGATGTACT TGAGTCTTGGGCATGTCAGTGT
IL-6 GAAACCGCTATGAAGTTCCTCTCTG TGTTGGGAGTGGTATCCTCTGTGA
IP-10 CAGGAGAATGAGGGCCATAGG CGGATTCAGACATCTCTGCTCAT
Table 3 Antibodies used
Antigen Host Dilution Source
NICD, cleaved at Val
1744
Rabbit 1:500 Cell Signaling
Jagged-1 Rabbit 1:500 Santa Cruz
β-actin Mouse 1:5000 Sigma-Aldrich
α-Tubulin Mouse 1:5000 Sigma-Aldrich
Iba1 Rabbit 1:2000 Wako
GFAP(GA5 clon) Mouse 1:500 Sigma-Aldrich
BrdU Mouse 1:50 Hybridoma Bank
GFAP Rabbit 1:500 Dako
c-myc (9E10) Mouse 1:500 Roche
Thy-1 (against CD90) Mouse 1:500 Bio-Rad (Formerly AbD
Serotec)
Anti-mouse-HRP Goat 1:10000 Jackson Laboratories
Anti-rabbit-HRP Goat 1:10000 Jackson Laboratories
Anti-mouse Alexa 488 Goat 1:1000 Jackson Laboratories
Anti-rabbit Alexa 594 Goat 1:1000 Jackson Laboratories
Anti-mouse Alexa 647 Goat 1:50 Invitrogen
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comparisons. When an interaction between two factors
was not detected, data were split and each factor was
analyzed by one-way ANOVA followed by Bonferroni or
Student’s t-test. The statistical signiﬁcance level was set at
p < 0.05.
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